Patents by Inventor Maurits W. Geerlings

Maurits W. Geerlings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and means for site directed therapy
    Patent number: 7374936
    Abstract: The present invention relates to the field of site directed therapy. More specifically the invention relates to site directed radio therapy, and provides a method for production of radioconjugates and an apparatus for radioimmunotherapy. The method, conjugates and apparatus can be practicalized without the need for radioactive shielding and/or airtight facilities. Without these restrictions the invention provides a simple and efficient means of therapy at the bed-side of the patient.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: May 20, 2008
    Assignee: Actinium Pharmaceuticals, Inc.
    Inventor: Maurits W Geerlings
  • Method and means for site directed therapy
    Publication number: 20020082389
    Abstract: The present invention relates to the field of site directed therapy. More specifically the invention relates to site directed radio therapy, and provides a method for production of radioconjugates and an apparatus for radioimmunotherapy. The method, conjugates and apparatus can be practicalized without the need for radioactive shielding and/or airtight facilities. Without these restrictions the invention provides a simple and efficient means of therapy at the bed-side of the patient.
    Type: Application
    Filed: December 17, 2001
    Publication date: June 27, 2002
    Inventor: Maurits W. Geerlings
  • Method and means for site directed therapy
    Patent number: 6403771
    Abstract: The present invention relates to the field of site directed therapy. More specifically the invention relates to site directed radio therapy, and provides a method for production of radioconjugates and an apparatus for radioimmunotherapy. The method, conjugates and apparatus can be practicalized without the need for radioactive shielding and/or airtight facilities. Without these restrictions the invention provides a simple and efficient means of therapy at the bed-side of the patient.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: June 11, 2002
    Assignee: Actinium Pharmaceuticals, Limited
    Inventor: Maurits W. Geerlings
  • Radioimmunotherapy using .alpha.-particles emission
    Patent number: 5246691
    Abstract: The present invention relates to the use of Actinium or one of its daughters in radioimmunotherapy. Also provided are immunoconjugates comprising an isotope, a chelating agent and a slowly localizing antibody. The invention also includes pharmaceutical compositions comprising said immunoconjugates, as well as such compositions comprising one or more scavenging agents. The compositions according to the invention are particularly useful for the treatment of micrometastases in adjuvant therapy, as well as for treatment of localized tumors.
    Type: Grant
    Filed: February 19, 1991
    Date of Patent: September 21, 1993
    Assignee: Akzo N.V.
    Inventors: Maurits W. Geerlings, Franciscus M. Kaspersen